Neil S. Forbes
Nature Reviews. Cancer · 2006–2010
A researcher in the Science corpus: 2 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Whom Neil S. Forbes trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Neil S. Forbes's perspective
Ordered by how strongly the researchers Neil S. Forbes trusts endorse each paper. Same corpus, a different order for every researcher.
- Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. (Journal of Clinical Oncology)
- Drug penetration in solid tumours (Nature Reviews. Cancer)
- Hypoxia — a key regulatory factor in tumour growth (Nature Reviews. Cancer)
- Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. (New England Journal of Medicine)
- Molecular imaging of cancer with positron emission tomography (Nature Reviews. Cancer)
- Tumour biology: Herceptin acts as an anti-angiogenic cocktail (Nature)
- Dissecting tumour pathophysiology using intravital microscopy (Nature Reviews. Cancer)
- Why do cancers have high aerobic glycolysis? (Nature Reviews. Cancer)
- Molecular regulation of vessel maturation (Nature Medicine)
- Exploiting tumour hypoxia in cancer treatment (Nature Reviews. Cancer)
Their papers
- Engineering the perfect (bacterial) cancer therapy (2010) — 837 citations
- Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers. (2006) — 760 citations